Hot Business News Today Study Favors Masimo's (MASI) SedLine for Better Patient Outcome by Zacks Equity Research • December 14, 2021 • 0 Comments Masimo’s (MASI) SedLine is expected to aid in the early identification of patients who are at risk of developing POD. Read more...
